{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T13:46:17Z","timestamp":1790689577800,"version":"4.1.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["GNT1118888"],"award-info":[{"award-number":["GNT1118888"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001793","name":"Queensland University of Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.biocel.2021.106094","type":"journal-article","created":{"date-parts":[[2021,10,9]],"date-time":"2021-10-09T04:23:39Z","timestamp":1633753419000},"page":"106094","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Cancer: The role of iron and ferroptosis"],"prefix":"10.1016","volume":"141","author":[{"given":"Gautam","family":"Rishi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2411-0576","authenticated-orcid":false,"given":"Gary","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4583-7790","authenticated-orcid":false,"given":"V. Nathan","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.biocel.2021.106094_bib1","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.3390\/cancers3033279","article-title":"Assessment of the evolution of cancer treatment therapies","volume":"3","author":"Arruebo","year":"2011","journal-title":"Cancers"},{"issue":"5","key":"10.1016\/j.biocel.2021.106094_bib2","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/ng1777","article-title":"Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression","volume":"38","author":"Babitt","year":"2006","journal-title":"Nat. Genet."},{"issue":"3","key":"10.1016\/j.biocel.2021.106094_bib3","doi-asserted-by":"crossref","first-page":"193","DOI":"10.7150\/ijms.3635","article-title":"Cancer and radiation therapy: current advances and future directions","volume":"9","author":"Baskar","year":"2012","journal-title":"Int. J. Med. Sci."},{"issue":"29","key":"10.1016\/j.biocel.2021.106094_bib4","doi-asserted-by":"crossref","first-page":"4089","DOI":"10.1038\/onc.2017.11","article-title":"Iron addiction: a novel therapeutic target in ovarian cancer","volume":"36","author":"Basuli","year":"2017","journal-title":"Oncogene"},{"issue":"7784","key":"10.1016\/j.biocel.2021.106094_bib5","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/s41586-019-1705-2","article-title":"The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis","volume":"575","author":"Bersuker","year":"2019","journal-title":"Nature"},{"issue":"4156","key":"10.1016\/j.biocel.2021.106094_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/bmj.2.4156.275","article-title":"Effects of precipitated silica and of iron oxide on the incidence of primary lung tumours in mice","volume":"2","author":"Campbell","year":"1940","journal-title":"Br. Med. J."},{"key":"10.1016\/j.biocel.2021.106094_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.607692","article-title":"Antibodies targeting the transferrin receptor 1 (TfR1) as direct anti-cancer agents","volume":"12","author":"Candelaria","year":"2021","journal-title":"Front Immunol."},{"issue":"11\u201312","key":"10.1016\/j.biocel.2021.106094_bib8","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1007\/s00018-016-2194-1","article-title":"Mechanisms of ferroptosis","volume":"73","author":"Cao","year":"2016","journal-title":"Cell Mol. Life Sci."},{"issue":"5","key":"10.1016\/j.biocel.2021.106094_bib9","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biocel.2021.106094_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2020.590226","article-title":"Iron metabolism in ferroptosis","volume":"8","author":"Chen","year":"2020","journal-title":"Front Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.biocel.2021.106094_bib11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nrd.2016.248","article-title":"Targeting iron metabolism in drug discovery and delivery","volume":"16","author":"Crielaard","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"issue":"183","key":"10.1016\/j.biocel.2021.106094_bib12","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005338","article-title":"Addressing safety liabilities of TfR bispecific antibodies that cross the blood-brain barrier","volume":"5","author":"Couch","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"47","key":"10.1016\/j.biocel.2021.106094_bib13","doi-asserted-by":"crossref","first-page":"82231","DOI":"10.18632\/oncotarget.19288","article-title":"Iron-responsive element-binding protein 2 plays an essential role in regulating prostate cancer cell growth","volume":"8","author":"Deng","year":"2017","journal-title":"Oncotarget"},{"issue":"5","key":"10.1016\/j.biocel.2021.106094_bib14","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.biocel.2021.106094_bib15","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.02523","article-title":"Pharmacological inhibition of cystine-glutamate exchange induces endoplasmic reticulum stress and ferroptosis","volume":"3","author":"Dixon","year":"2014","journal-title":"Elife"},{"issue":"6","key":"10.1016\/j.biocel.2021.106094_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.175","article-title":"NUPR1, a new target in liver cancer: implication in controlling cell growth, migration, invasion and sorafenib resistance","volume":"7","author":"Emma","year":"2016","journal-title":"Cell Death Dis."},{"issue":"18","key":"10.1016\/j.biocel.2021.106094_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/pmic.201800311","article-title":"GPX4 at the crossroads of lipid homeostasis and ferroptosis","volume":"19","author":"Forcina","year":"2019","journal-title":"Proteomics"},{"issue":"5a","key":"10.1016\/j.biocel.2021.106094_bib18","first-page":"3059","article-title":"Iron accumulation in mammary tumor suggests a tug of war between tumor and host for the microelement","volume":"27","author":"Freitas","year":"2007","journal-title":"Anticancer Res."},{"issue":"7","key":"10.1016\/j.biocel.2021.106094_bib19","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41568-019-0149-1","article-title":"Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion","volume":"19","author":"Friedmann Angeli","year":"2019","journal-title":"Nature Rev. Cancer"},{"issue":"6","key":"10.1016\/j.biocel.2021.106094_bib20","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1158\/0008-5472.CAN-20-3477","article-title":"Ferroptosis inducers are a novel therapeutic approach for advanced prostate cancer","volume":"81","author":"Ghoochani","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.biocel.2021.106094_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/bs.vh.2019.01.002","article-title":"Hepcidin-ferroportin axis in health and disease","volume":"110","author":"Ginzburg","year":"2019","journal-title":"Vitam. Horm."},{"issue":"8","key":"10.1016\/j.biocel.2021.106094_bib22","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1002\/1097-0142(19921015)70:8<2051::AID-CNCR2820700806>3.0.CO;2-1","article-title":"Antitumor effect of deferoxamine on human hepatocellular carcinoma growing in athymic nude mice","volume":"70","author":"Hann","year":"1992","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.biocel.2021.106094_bib23","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s10534-021-00312-1","article-title":"In vitro identification and characterisation of iron chelating catechol-containing natural products and derivatives","volume":"34","author":"Hawula","year":"2021","journal-title":"Biometals"},{"issue":"4","key":"10.1016\/j.biocel.2021.106094_bib24","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell. Biol."},{"issue":"51","key":"10.1016\/j.biocel.2021.106094_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/adma.201904197","article-title":"Recent progress in ferroptosis inducers for cancer therapy","volume":"31","author":"Liang","year":"2019","journal-title":"Adv. Mater."},{"issue":"1","key":"10.1016\/j.biocel.2021.106094_bib26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41467-021-20904-2","article-title":"NUPR1 is a critical repressor of ferroptosis","volume":"12","author":"Liu","year":"2021","journal-title":"Nature Comm."},{"issue":"2","key":"10.1016\/j.biocel.2021.106094_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/emmm.201100190","article-title":"N-myc downstream regulated gene 1 modulates Wnt-beta-catenin signalling and pleiotropically suppresses metastasis","volume":"4","author":"Liu","year":"2012","journal-title":"EMBO Mol. Med."},{"issue":"7","key":"10.1016\/j.biocel.2021.106094_bib28","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/ijc.28159","article-title":"Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib","volume":"133","author":"Louandre","year":"2013","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.biocel.2021.106094_bib29","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1038\/nchem.2778","article-title":"Salinomycin kills cancer stem cells by sequestering iron in lysosomes","volume":"9","author":"Mai","year":"2017","journal-title":"Nat. Chem."},{"issue":"7860","key":"10.1016\/j.biocel.2021.106094_bib30","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1038\/s41586-021-03539-7","article-title":"DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer","volume":"593","author":"Mao","year":"2021","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.biocel.2021.106094_bib31","first-page":"239","article-title":"A review on iron chelators in treatment of iron overload syndromes","volume":"10","author":"Mobarra","year":"2016","journal-title":"Int. J. Hematol. Oncol. Stem Cell Res."},{"issue":"10","key":"10.1016\/j.biocel.2021.106094_bib32","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41557-020-0513-5","article-title":"CD44 regulates epigenetic plasticity by mediating iron endocytosis","volume":"12","author":"M\u00fcller","year":"2020","journal-title":"Nat. Chem."},{"issue":"4","key":"10.1016\/j.biocel.2021.106094_bib33","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1084\/jem.20180900","article-title":"Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis","volume":"216","author":"Muto","year":"2019","journal-title":"J. Exp. Med."},{"issue":"20","key":"10.1016\/j.biocel.2021.106094_bib34","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJM198511143132004","article-title":"Survival and causes of death in cirrhotic and in noncirrhotic patients with primary hemochromatosis","volume":"313","author":"Niederau","year":"1985","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.biocel.2021.106094_bib35","doi-asserted-by":"crossref","DOI":"10.1093\/mtomcs\/mfab021","article-title":"Chemistry and biology of ferritin","volume":"13","author":"Plays","year":"2021","journal-title":"Metallomics"},{"issue":"9","key":"10.1016\/j.biocel.2021.106094_bib36","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41556-020-0565-1","article-title":"Ferroptosis occurs through an osmotic mechanism and propagates independently of cell rupture","volume":"22","author":"Riegman","year":"2020","journal-title":"Nat. Cell Biol."},{"issue":"3","key":"10.1016\/j.biocel.2021.106094_bib37","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20150014","article-title":"Hepcidin: regulation of the master iron regulator","volume":"35","author":"Rishi","year":"2015","journal-title":"Biosci. Rep."},{"issue":"1","key":"10.1016\/j.biocel.2021.106094_bib38","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.celrep.2014.02.042","article-title":"Iron metabolism regulates p53 signaling through direct heme-p53 interaction and modulation of p53 localization, stability, and function","volume":"7","author":"Shen","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.biocel.2021.106094_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/JCI143691","article-title":"HIF-2\u03b1 activation potentiates oxidative cell death in colorectal cancers by increasing cellular iron","author":"Singhal","year":"2021","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.biocel.2021.106094_bib40","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.28251","article-title":"Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells","volume":"63","author":"Sun","year":"2016","journal-title":"Hepatology"},{"issue":"45","key":"10.1016\/j.biocel.2021.106094_bib41","doi-asserted-by":"crossref","first-page":"5617","DOI":"10.1038\/onc.2015.32","article-title":"HSPB1 as a novel regulator of ferroptotic cancer cell death","volume":"34","author":"Sun","year":"2015","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.biocel.2021.106094_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"issue":"4","key":"10.1016\/j.biocel.2021.106094_bib43","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.390","article-title":"Deubiquitinase USP35 modulates ferroptosis in lung cancer via targeting ferroportin","volume":"11","author":"Tang","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.biocel.2021.106094_bib44","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1146\/annurev-nutr-082117-051732","article-title":"Iron and Cancer","volume":"38","author":"Torti","year":"2018","journal-title":"Ann. Rev. Nutr."},{"issue":"5","key":"10.1016\/j.biocel.2021.106094_bib45","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/nrc3495","article-title":"Iron and cancer: more ore to be mined","volume":"13","author":"Torti","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.biocel.2021.106094_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.mam.2020.100860","article-title":"Iron: the cancer connection","volume":"75","author":"Torti","year":"2020","journal-title":"Mol. Aspects Med."},{"issue":"8","key":"10.1016\/j.biocel.2021.106094_bib47","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1080\/01635581.2019.1609053","article-title":"Serum biomarkers of iron status and risk of primary liver cancer: a systematic review and meta-analysis","volume":"71","author":"Tran","year":"2019","journal-title":"Nutr. Cancer"},{"key":"10.1016\/j.biocel.2021.106094_bib48","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.2147\/DDDT.S199459","article-title":"Role of GRP78 inhibiting artesunate-induced ferroptosis in KRAS mutant pancreatic cancer cells","volume":"13","author":"Wang","year":"2019","journal-title":"Drug Des. Devel. Ther."},{"issue":"1","key":"10.1016\/j.biocel.2021.106094_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3390\/ijms20010095","article-title":"Iron metabolism in cancer","volume":"20","author":"Wang","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.biocel.2021.106094_bib50","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1016\/j.celrep.2017.07.055","article-title":"The tumor suppressor p53 limits ferroptosis by blocking DPP4 activity","volume":"20","author":"Xie","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.biocel.2021.106094_bib51","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.3389\/fnins.2019.01443","article-title":"Iron metabolism, ferroptosis, and the links with Alzheimer\u2019s disease","volume":"13","author":"Yan","year":"2020","journal-title":"Front Neurosci."},{"issue":"1\u20132","key":"10.1016\/j.biocel.2021.106094_bib52","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.cell.2013.12.010","article-title":"Regulation of ferroptotic cancer cell death by GPX4","volume":"156","author":"Yang","year":"2014","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.biocel.2021.106094_bib53","doi-asserted-by":"crossref","first-page":"953","DOI":"10.4161\/cc.27818","article-title":"Invading cancer cells are predominantly in G0\/G1 resulting in chemoresistance demonstrated by real-time FUCCI imaging","volume":"13","author":"Yano","year":"2014","journal-title":"Cell cycle"},{"issue":"6","key":"10.1016\/j.biocel.2021.106094_bib54","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.cmet.2020.10.011","article-title":"The metabolic underpinnings of ferroptosis","volume":"32","author":"Zheng","year":"2020","journal-title":"Cell Metab."},{"issue":"7826","key":"10.1016\/j.biocel.2021.106094_bib55","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/s41586-020-2732-8","article-title":"Plasticity of ether lipids promotes ferroptosis susceptibility and evasion","volume":"585","author":"Zou","year":"2020","journal-title":"Nature"}],"container-title":["The International Journal of Biochemistry &amp; Cell Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272521001758?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1357272521001758?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:29:40Z","timestamp":1778801380000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1357272521001758"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":55,"alternative-id":["S1357272521001758"],"URL":"https:\/\/doi.org\/10.1016\/j.biocel.2021.106094","relation":{},"ISSN":["1357-2725"],"issn-type":[{"value":"1357-2725","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancer: The role of iron and ferroptosis","name":"articletitle","label":"Article Title"},{"value":"The International Journal of Biochemistry & Cell Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biocel.2021.106094","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106094"}}